Published by mark itwired
Posted on July 30, 2021
A report of Future Market
Insights titled “Global Radiation Dose Optimisation Software Market:
Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” states that favourable government regulations for
controlling radiation are likely to have a positive impact on the growth of the
global radiation dose optimisation
software market in the years ahead. Doctors
are using radiation dose optimisation software for monitoring and controlling
the doses of radiation. Correspondingly, radiation dose optimisation software
is used for controlling multiple aspects related to the dose. The radiation
dose quantity varies as per the patient and the disease. The global market for
radiation dose optimisation software is expected to rise at a CAGR of 27.4%
from 2017 to 2027.
To
Get Sample Copy of Report Visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6238
Inclination
Towards Smart Technology to Accelerate Adoption
With technology becoming ubiquitous and advanced technologies
replacing existing ones, the demand for more cutting-edge technology is rising
with each passing day. Consumers are gaining awareness about the availability
of advanced technologies for treating diseases such as smart technology
products. As a result of this, the demand for radiation dose optimisation
software has also taken a surge and is expected to foresee the same trend in
the coming years. The need to monitor the limits of annual dose of the workers
in CT/PET imaging is also one of the factors that will have an influential
impact on the market in the long run. The growing adoption of electronic health
recording systems along with a rising awareness regarding radiation safety is
expected to bode well for the market in the near future. However, the dearth of
expert operators and the lack of knowledge and training among the existing
workers for operating radiation dose optimisation software might act as a
roadblock in the progress of the market during the course of the forecast
period.
North
America to Take the Lead in Terms of Deployment
In order to avoid high dosage of radiation and for increasing
the safety of workers, the U.S. government has introduced a number of
reimbursement policies for radiologists for encouraging them to follow the
various guidelines that have been set up by several organisations to maintain
proper dose levels. As a result of these stringent regulatory requirements, the
adoption of radiation dose optimisation software is expected to increase during
the forecast period. As a result of these dynamics, the market for radiation
dose optimisation software in North America is expected to witness an
outstanding CAGR of 30.8% over the course of the forecast period.
For More Details, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-6238
Other than this, on the basis of end user, the market has been
segmented into hospitals, diagnostic centres, cancer research institutes, and
others. Based on component the market has been bifurcated into software and
services. The software segment has been further divided into automatic and
manual and the services segment has been further divided into education and
training and support.
Companies
to Strengthen Product Offering for Cancer Diagnosis
Product innovation, expansion in product portfolio, and
acquisitions are likely to be the key areas that companies operating in the
global radiation dose optimisation software market are likely to focus on in
the coming years. Some of the leading companies in the market are General
Electric Company, Koninklijke Philips N.V., Siemens AG, Agfa-Gevaert Group,
Bracco, Sectra AB, and FUJIFILM Holdings Corporation.
More about Technology Market Insights:
Business
Analytics BPO Services Market
A report of Future Market
Insights titled “Global Radiation Dose Optimisation Software Market:
Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” states that favourable government regulations for
controlling radiation are likely to have a positive impact on the growth of the
global radiation dose optimisation
software market in the years ahead. Doctors
are using radiation dose optimisation software for monitoring and controlling
the doses of radiation. Correspondingly, radiation dose optimisation software
is used for controlling multiple aspects related to the dose. The radiation
dose quantity varies as per the patient and the disease. The global market for
radiation dose optimisation software is expected to rise at a CAGR of 27.4%
from 2017 to 2027.
To
Get Sample Copy of Report Visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6238
Inclination
Towards Smart Technology to Accelerate Adoption
With technology becoming ubiquitous and advanced technologies
replacing existing ones, the demand for more cutting-edge technology is rising
with each passing day. Consumers are gaining awareness about the availability
of advanced technologies for treating diseases such as smart technology
products. As a result of this, the demand for radiation dose optimisation
software has also taken a surge and is expected to foresee the same trend in
the coming years. The need to monitor the limits of annual dose of the workers
in CT/PET imaging is also one of the factors that will have an influential
impact on the market in the long run. The growing adoption of electronic health
recording systems along with a rising awareness regarding radiation safety is
expected to bode well for the market in the near future. However, the dearth of
expert operators and the lack of knowledge and training among the existing
workers for operating radiation dose optimisation software might act as a
roadblock in the progress of the market during the course of the forecast
period.
North
America to Take the Lead in Terms of Deployment
In order to avoid high dosage of radiation and for increasing
the safety of workers, the U.S. government has introduced a number of
reimbursement policies for radiologists for encouraging them to follow the
various guidelines that have been set up by several organisations to maintain
proper dose levels. As a result of these stringent regulatory requirements, the
adoption of radiation dose optimisation software is expected to increase during
the forecast period. As a result of these dynamics, the market for radiation
dose optimisation software in North America is expected to witness an
outstanding CAGR of 30.8% over the course of the forecast period.
For More Details, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-6238
Other than this, on the basis of end user, the market has been
segmented into hospitals, diagnostic centres, cancer research institutes, and
others. Based on component the market has been bifurcated into software and
services. The software segment has been further divided into automatic and
manual and the services segment has been further divided into education and
training and support.
Companies
to Strengthen Product Offering for Cancer Diagnosis
Product innovation, expansion in product portfolio, and
acquisitions are likely to be the key areas that companies operating in the
global radiation dose optimisation software market are likely to focus on in
the coming years. Some of the leading companies in the market are General
Electric Company, Koninklijke Philips N.V., Siemens AG, Agfa-Gevaert Group,
Bracco, Sectra AB, and FUJIFILM Holdings Corporation.
More about Technology Market Insights:
Business
Analytics BPO Services Market
Explore more articles in the Research Reports category
